Accessibility Menu
 
Rubicon Organics logo

Rubicon Organics

(OTC) ROMJF

Current Price$0.37
Market Cap$24.50M
Since IPO (2018)-78%
5 Year-87%
1 Year+10%
1 Month+12%

Rubicon Organics Financials at a Glance

Market Cap

$24.50M

Revenue (TTM)

$57.19M

Net Income (TTM)

$3.23M

EPS (TTM)

$0.03

P/E Ratio

10.85

Dividend

$0.00

Beta (Volatility)

0.39 (Low)

Price

$0.37

Volume

217

Open

$0.37

Previous Close

$0.37

Daily Range

$0.37 - $0.37

52-Week Range

$0.28 - $0.54

ROMJF News

No articles available.

ROMJF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rubicon Organics

Industry

Pharmaceuticals

Employees

210

CEO

Margaret Brodie, CPA

Headquarters

Vancouver, BC V6C 1A5, CA

ROMJF Financials

Key Financial Metrics (TTM)

Gross Margin

41%

Operating Margin

7%

Net Income Margin

6%

Return on Equity

8%

Return on Capital

8%

Return on Assets

5%

Earnings Yield

9.22%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$24.50M

Shares Outstanding

67.18M

Volume

217

Short Interest

0.00%

Avg. Volume

23.98K

Financials (TTM)

Gross Profit

$15.42M

Operating Income

$1.17M

EBITDA

$1.86M

Operating Cash Flow

$3.40M

Capital Expenditure

$1.55M

Free Cash Flow

$1.85M

Cash & ST Invst.

$11.24M

Total Debt

$9.89M

Rubicon Organics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$15.63M

+15.8%

Gross Profit

$8.04M

+107.3%

Gross Margin

51.44%

N/A

Market Cap

$24.50M

N/A

Market Cap/Employee

$117.78K

N/A

Employees

208

N/A

Net Income

$2.83M

+1778.4%

EBITDA

$3.79M

+309.4%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$2.64M

-86.4%

Accounts Receivable

$5.67M

-9.3%

Inventory

$20.27M

+81.9%

Long Term Debt

$7.95M

+19069.3%

Short Term Debt

$1.37M

-87.5%

Return on Assets

4.93%

N/A

Return on Invested Capital

7.71%

N/A

Free Cash Flow

$213.59K

-140.5%

Operating Cash Flow

$451.30K

-52.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GBLPGlobal Pharmatech, Inc.
$0.05+0.00%
HSTIHigh Sierra Technologies, Inc.
$1.40+0.00%
MEDIFMediPharm Labs Corp.
$0.05-3.11%
VYYRFVoyageur Pharmaceuticals Ltd.
$0.10+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%

Questions About ROMJF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.